-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
-
L’utilisation de la thérapie cellulaire pour traiter les patients atteints du COVID-19 peut réduire le risque de décès dû à la maladie de 60 %, selon une revue systématique et une méta-analyse menée par des chercheurs de l’Université de São Paulo (USP) au Brésil, en partenariat avec des collègues en Allemagne et aux États-Unis.
Leurs conclusions sont rapportées dans un article [...]
-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
-
New Delhi, Sep 19 (SocialNews.XYZ) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University [...]
-
नई दिल्ली: एक नए अध्ययन के अनुसार, सीओवीआईडी -19 रोगियों के इलाज के लिए सेल थेरेपी के उपयोग से बीमारी से मृत्यु का जोखिम 60 प्रतिशत तक कम हो सकता है।
व्यवस्थित समीक्षा और मेटा-विश्लेषण में [...]
-
New Delhi, Sep 19 (IANS) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University of Sao Paulo [...]
-
Cell therapy effective in reducing the risk of deaths due to Covid-19 : एक नए शोध के अनुसार, कोविड-19 रोगियों के इलाज में सेल थेरेपी का उपयोग करने से मृत्यु के जोखिम को 60 प्रतिशत तक कम किया जा सकता है।
Cell therapy effective in reducing the risk of deaths due to COVID-19 : एक नए [...]
-
Researchers from the University of São Paulo (USP) in Brazil, in collaboration with colleagues from Germany and the United States, conducted a systematic review and meta-analysis, which revealed a promising aspect of cell therapy in treating COVID-19. According to their findings, published in the journal Frontiers in Immunology, cell therapy can potentially reduce the risk of death from the disease by 60%.
This comprehensive review encompassed 195 clinical trials conducted in 30 [...]
-
New Delhi, Sep 19 (IANS) The use of cell therapy to treat COVID-19 patients can reduce the risk of death from the disease by 60 per cent, according to a new study.The systematic review and meta-analysis covered 195 clinical trials of advanced cell therapies targeting COVID-19 that were conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with outcomes published by July 2022.
The findings of the study, conducted by researchers at the University of Sao Paulo [...]
-
New Delhi: The use of cell therapy to treat COVID-19 patients could reduce the risk of death from the disease by 60 per cent, according to a new study.
The systematic review and meta-analysis included 195 clinical trials of advanced cell therapies targeting COVID-19 conducted in 30 countries between January 2020 and December 2021, as well as 26 trials with results published by July 2022. to be done.
The findings of the study, conducted by researchers at the University of São Paulo [...]
